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Abstract

EXPRESSION OF FOREIGN GENES IN THE Pseudomonas BACTERIOPHAGE Pf3
By Krystin Virginia Weathers, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Bioinformatics at Virginia Commonwealth University.
Virginia Commonwealth University, 2012
Major Director: Dr. Luiz Shozo Ozaki, Associate Professor, Center for the Study of Biological
Complexity

Filamentous bacteriophages were engineered to express foreign genes with the ultimate
purpose of displaying transmission control anti-malarial peptides as in phage display. It was
hypothesized that expression of foreign genes would be possible using the phage’s promoters.
This hypothesis was tested by assuming that promoters for the phage major coat protein (MCP)
gene would also promote the expression of any foreign gene inserted downstream of the MCP
gene. As proof of principle, the bacteriophages Pf3, Pf1, and M13 were engineered in this way to
successfully synthesize Enhanced Green Fluorescent Protein (EGFP). Type 88 phage display on
the EGFP recombinant Pf3 was attempted by fusing a second copy of its MCP gene to the
existing EGFP gene. This resulted in a phage display Pf3 replacement vector which was then
used to construct a phage for displaying an anti-malarial peptide.

1. Introduction

1.1 Bacteriophages
There are an estimated 1031 different bacteriophages (phages) on earth (Breitbart, 2005).
Phages are the largest group of biological entities found in the world (Ackermann, 2003). Even
though phages outnumber all other entities on earth, relatively little is known about most of
them. There is a tremendous potential for scientific advancement through the use of phages in
several fields including biomedical research and nanotechnology (Rakonjac, 2011; Dang, 2011;
Chandler, 2011).
As Ackermann cited, there are thirteen different families of phages (Table 1, Figure 1,
Ackermann, 2003).
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Table 1: Bacteriophages and their distinguishing features*
Family Name

Distinguishing Features

Microviridae

Polyhedral shape; Single-stranded, circular DNA

Myoviridae

Contractile tail; Double-stranded, linear DNA

Siphoviridae

Long, non-contractile tail; Double-stranded linear DNA

Podoviridae

Short, non-contractile tail; Double-stranded linear DNA

Corticoviridae

Complex capsid; lipids; Double-stranded, circular DNA

Tectiviridae

Double-stranded, linear DNA; Internal lipoprotein vesicle

Lipothrixviridae

Envelope; lipids; Double-stranded, linear DNA

Plasmaviridae

Envelope; Lipids; No capsid; Double-stranded, circular DNA

Rudiviridae

Helical rods; Double-stranded, lineasr DNA

Fuselloviridae

Spindle-shaped; no capsid; Double-stranded, circular DNA

Inoviridae

Rods or filaments; Single-stranded, circular DNA

Leviviridae

Single-stranded, linear RNA

Cystoviridae

Double-stranded, linear RNA

* Ackermann, 2003
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Figure 1: Morphologies of bacteriophages. (Reprinted with permission from Ackermann, H.W.
(2003). Bacteriophage observations and evolution. Research in Microbiology, 154, 245-251.
Copyright 2003 Elsevier).
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Phages in each family have different morphological and genomic characteristics. For
example, all Siphoviridae have long non-contractile tails and a double-stranded DNA genome,
while the Leviviridae lack tails, and have ssRNA genomes surrounded by a simple capsid. Phage
genomes may be either DNA or RNA and may be single stranded or double stranded. All phages
use the replication system of their host cell; some completely take over the host and eventually
cause cell lysis while others are able to replicate without severely disrupting the host cell. Some
phages are able to integrate into the host bacterial cell genome where they may propagate or
remain dormant until triggered by some environmental factor. This study will focus on the
Inoviridae, which are filamentous phages with a single-stranded DNA genome.
The genomes of all phages from the family Inoviridae are composed of circular, singlestranded DNA which, once inside the host cell, is converted into double stranded DNA, known
as the replicative form, and replicates by a rolling circle mechanism (Gilbert and Dressler, 1968).
The genera Plectrovirus and Inovirus include filamentous phages, thusly named for their long,
rod like shape. The Inoviridae lack genes encoding proteins that lyse their host bacteria. Because
they replicate without killing their host, filamentous phages may be produced and extruded by
the host cell indefinitely (Paschke, 2006). Some filamentous phages integrate into the host
genome and become temperate while others not (Rakonjac, 2011). The majority of hosts for
filamentous phages are Gram negative bacteria but there are two known filamentous phages with
Gram positive bacterial hosts (Rakonjac, 2011). Filamentous phage hosts display a pilus, which
is how the phage initially interacts with the bacteria (Iannolo, 1995; Russel, 1997).

In

filamentous phage M13, 1) the N-terminal domain of protein III at the end of the phage attaches
to the F pilus, 2) the pilus retracts to the bacterial cell drawing the phage in, 3) it interacts with a
secondary receptor and then 4) it is allowed to enter the cell with the N-terminal domain of
4

protein III entering first (Smith, 1997). As the phage enters the cell, the coat proteins encasing
the phage genome are removed (Russel, 1997). Upon completion of phage genome replication, a
copy of the DNA is encased by the phage’s coat proteins as it passes through the cell membrane
exiting the cell; the first portion of the phage to emerge from the cell is the packaging signal end
(Russel, 1997).
The best studied group of filamentous phages is the Ff group which includes M13, fd and
f1; the following discussion of genome contents and phage structure is based on this group
(Russel, 1997; Rakonjac 2011). The DNA of a filamentous phage codes for the production of
ten to eleven proteins (Figure 2).

5

Figure 2: Genome map of model filamentous phage M13. Each gene is indicated by the red
circular arrows and the gene number is indicated in roman numerals. Genome map created using
CGView.
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Of these, 5 are assembled into the phage coat. The major coat protein, encoded by gene
VIII, covers the body of the phage while the ends are covered by minor coat proteins, encoded
by genes III, VI, VII, and IX (Rakonjac, 2011). Genes II, V, and X, are responsible for DNA
synthesis while genes I and IV are responsible for phage assembly (Russel, 1997). Filamentous
phages are structured such that their genomes are encapsidated in proteins.

There are

approximately 2700 copies of the major coat protein surrounding the single-stranded phage DNA
(Wang, 2010). Approximately 5 copies of each of the minor coat proteins can be found on the
phage coat; 5 copies of protein IV and 5 copies of protein III on one end and 5 copies of protein
VII and 5 copies of protein IX on the other end (Wang, 2010). Proteins VII and IX are essential
for phage particle assembly while proteins III and IV are necessary for stability and infectivity.
More specifically, protein III is responsible for interaction with the bacterial host F pilus as well
as removing the phage coat and allowing the genome access to the host cell’s cytoplasm (Russel,
1997). There are several ways in which the phage may exit its host cell. In some filamentous
phages, protein IV, which is homologous to host secretins, may form a complex in the membrane
to create a gated channel for the phage to exit through (Iannolo, 1995). Alternatively, as in
phage CTXФ, the phage may use the host cell secretins but phage production is very low in these
systems, indicating a lower efficiency in using host secretins (Rakonjac, 2011).
1.2 Phage Display
Smith first proposed creating a “fusion phage” in which a foreign peptide was fused to
protein III of filamentous phage f1 (Smith, 1985). The widely used technology of phage display
arose from this. In phage display, a foreign peptide is fused to a phage coat protein, usually
protein III or VIII and a spacer, or hinge, may be used to distance the foreign peptide from the
phage (Smith, 1997; Kim, 2004). While proteins III and VIII are the most frequently used, any
7

phage coat protein may be used to link a foreign peptide for phage display. The peptides are
situated on the N-terminal side of either protein III or VIII so that they are exposed on the
surface of the phage as opposed to being internalized (Smith, 1997). There are 20 amino acids of
protein VIII naturally exposed on the surface of the phage, which provide a large target for
attaching a foreign peptide (Kim, 2004). The expressed foreign peptide generally acts as if it
were not attached to the phage coat because of its accessibility to solvent and any spacers or
hinges that are used (Smith, 1997).
There are six popular models of phage display that are theoretically possible: Type 3,
Type 33, Type 3+3, Type 8, Type 88, and Type 8+8 as shown in Figure 3 (Smith, 1997).
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Figure 3: Types of phage display. The black boxes in the genome indicate the location of gene 8
or derivatives of gene 8 while the white boxes indicate the location of gene 3 or gene 3
derivatives. The grayed box indicates the location of the foreign peptide in each construct. The
grayed spheres indicate the location of the foreign gene on the phage coat. (Reprinted with
permission from Smith, G.P. and Petrenko, V.A. (1997). Phage Display. Chemistry Review, 97,
391-410. Copyright 1997 American Chemical Society).

9

In Type 3 and Type 8 phage display, the DNA sequence for the foreign peptide is directly
fused to the one and only copy of the given coat protein gene, protein III or protein VIII
respectively, and thereby should be expressed on every copy of that coat protein on the phage
(Smith, 1997). These two types of phage display are rarely viable because the foreign peptide
disrupts the ability of the coat proteins to align correctly around the phage DNA. Only small
peptides of fewer than 8 amino acids may be used in this type of phage display (Smith, 1997). In
Type 33 and Type 88 phage display, a second copy of the given coat protein gene is inserted into
the genome of the phage and that second copy is fused to the foreign peptide (Smith, 1997). In
this type of system the phage itself produces both the wild type coat protein as well as the fusion
coat protein. Upon phage assembly a few of the fusion coat proteins may be incorporated on to
the phage coat without disrupting the coat protein alignment and thereby producing viable
phages; this dual-expression system allows for the use of large foreign peptides (Smith, 1997).
Type 3+3 and Type 8+8 systems require two genetic elements; the phage contains the wild type
coat protein, this entity is usually called the “helper phage”. An accompanying plasmid contains
the coding sequence for the phage’s coat protein gene fused to the foreign peptide gene, this is
usually called the “phagemid” (Smith, 1997). Within Type 3+3 and Type 8+8 the same principle
of having the foreign peptide on only a few copies of the phage coat applies and creates a viable
phage. The requirement of two genetic elements increases the difficulty of engineering a Type
88 or Type 33 phage display system but is the most commonly used type of phage display
(Smith, 1997).

In order to use type 8+8 or type 3+3 phage display, a plasmid must be

characterized for the host bacteria. In types 33 and 3+3 it is common to only have one or fewer
copies of the foreign peptide displayed (or expressed) on each phage, since gene III is a minor
protein and present in just a few copies per phage. The number of foreign peptides exposed in
10

types 88 and 8+8 depends upon the size of the foreign peptide (Wang, 2010). Smaller peptides
tend to be expressed in higher numbers because the space on the phage coat is limited and higher
numbers of small peptides are able to fit together.
There are a wide range of applications for phage display that use the same concept of
fusing a foreign peptide to a phage coat protein to explore the molecular interactions of the
foreign peptide. These applications include the detection of monoclonal antibodies (Wang,
2010) and the study of molecular interactions (Lanzillotti, 2007).

To study molecular

interactions, the peptide on the phage coat mimics a ligand to probe receptors (Lanzillotti, 2007).
Additionally, phage display is the basis for the creation of peptide and protein libraries (Wang,
2010) to enable the screening of a large number of molecules in an interaction assay. Hostparasite interactions may also be discovered and characterized through phage display
(Lanzillotti, 2007). The biggest advantage of phage display is the ability to recover the phages
and identify the peptide that is attached (Wang, 2010). Alternatively, a sample may be probed
with free peptides which can not be recovered in large quantities.
Our specific interest is to use phage display to study ligand-receptor interactions of a
host-pathogen system. One of the most extensively researched host-pathogen interactions is of
the malaria parasite, Plasmodium, with its mosquito host.

Within the mosquito host, the

parasite’s lifecycle can be interrupted by blocking the molecular interaction between the parasite
and the mosquito tissue. Phage infecting bacteria residing in the mosquito gut may provide an
opportunity to use phage display as a novel anti-malarial approach. The following sections will
describe the disease and preliminary work to create a phage display system to block transmission
of Plasmodium.
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1.3 Malaria: The Disease and the Parasite
Malaria dates back over four thousand years in recorded history and has had a large
influence on shaping human history and populations (CDC, 2010). Each year approximately
1500 cases of malaria are diagnosed in the United States; most of these cases occur in travelers
and immigrants from areas where malaria is present (CDC, 2010). There is also the possibility
of native mosquitoes becoming infected by travelers from malaria endemic regions and then
transmitting the infection to residents (CDC, 2010). Even though malaria has been officially
eradicated in the United States, the three main mosquito vectors, Anopheles quadrimaculatus,
Anopheles freeborni, and Anopheles albimans, are still present meaning there is still a risk of a
malaria outbreak (CDC, 2010). While malaria does not pose a significant and immediate health
risk in the United States, it is still a large problem in many countries.
Approximately half of the world’s population lives in areas which put them at risk to
contract malaria (CDC, 2010). Over a million people are killed by the disease worldwide each
year (CDC, 2010).

Malaria is the second most deadly disease in Africa; second only to

HIV/AIDS (CDC, 2010). Sub-Saharan Africa is most strongly affected by the disease; in the
year 2008, there were approximately 200 million cases of malaria worldwide with approximately
one million people dying of the disease in sub-Saharan Africa, the majority of them children
(CDC, 2010).
Malaria is caused by parasites of the genus Plasmodium. There are over one hundred
known species of Plasmodium. These species are thought to be host specific, and can infect
assorted animals ranging from reptiles to birds to mammals including humans (CDC, 2010). Of
the numerous species of Plasmodium, only five are known to infect humans; those are
Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and
12

Plasmodium knowlesi (CDC, 2010). Of the human malarias, P. falciparum is the most deadly,
killing approximately one million people each year; however, P. vivax is the most prevalent
(CDC, 2010).
The lifecycle of Plasmodium entails infection of an invertebrate as well as a vertebrate
host (Figure 4; CDC, 2010).
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Figure 4: The lifecycle of the malaria parasite. Here the lifecycle of the parasite can be seen in
both the invertebrate host, the mosquito, and the vertebrate host, in this case, a human. The
development from ookinete to oocyst can be hindered by the SM1 peptide. The peptide blocks
the ookinete interaction with a receptor in the mosquito midgut essential for its differentiation
into an oocyst. "Life cycle of the malaria parasite" from Epidemiology of Infectious Diseases.
Available at: http://ocw.jhsph.edu. Copyright © Johns Hopkins Bloomberg School of Public
Health. Creative Commons BY-NC-SA.
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Female mosquitoes serve as the invertebrate host of Plasmodium (CDC, 2010). Even
though there are approximately four hundred and thirty Anopheles species, only thirty to forty
species are able to transmit mammalian malaria parasites (CDC, 2010). Plasmodium
gametocytes are found in the bloodstream of infected mammalian hosts; the gametocytes are
transferred to Anopheline mosquitoes during a blood meal which is needed for egg production
(CDC, 2010). In the mosquito mid-gut the two forms of gametocytes, macro- and
microgametocytes, fuse to form the zygote, which develops into the ookinete. The ookinete
traverses the midgut epithelium forming the oocysts. Upon maturation, the oocyst ruptures
thereby releasing sporozoites which then migrate to the salivary glands (CDC, 2010). These
sporozoites are then injected with the mosquito’s saliva into the next human blood meal host
(CDC, 2010). Once inside the newly infected human host, Plasmodium travels to the liver where
it develops into a schizont. The schizont ruptures, allowing between thirty thousand and forty
thousand merozoites to enter the blood stream and parasitize the red blood cells of the human
host. These merozoites develop into gametocytes, perpetuating the life cycle of the parasite
(CDC, 2010). Targets for blocking parasite development are at the critical steps in the life cycle
such as the step where the parasite interacts with the epithelium in the mosquito midgut (red
arrow, Figure 3).
1.4 Transmission Controls of Malaria
One avenue for controlling the spread of malaria is through the control of parasite
transmission, either by directly affecting the insect or through genetic engineering of the insect,
rendering it unsuitable for the parasite. Control options in which the insect is directly affected
include killing the insect with insecticides, bed nets impregnated with insecticides, the use of
attractants and traps, and controlling the larval habitat. These methods are not always possible or
15

effective. For instance a country needs to be able to afford the control option and the people of
the country need to be willing to use the control option. Additionally, many countries lack the
infrastructure to educate their people about transmission control methods. Also of consideration
is resistance to insecticides arising from frequent, high-volume use (Hemingway, 2000).
Two current genetic models for hindering the Plasmodium parasite include transgenesis,
in which the mosquito host is manipulated, and paratransgenesis, in which the bacteria inhabiting
the mosquito host are altered. Both of these methods pose the similar issue of releasing a
genetically altered, living organism into the environment. Transgenesis models have not been
only created for malaria; other vector borne diseases have been targeted as well.

A few

transgenesis models for malaria have been created which show great promise. One transgenesis
model was created using a blocking protein that reduces oocyst formation by 81.6% on average.
Another model promoting increased amounts of a naturally occurring peptide reduced oocyst
formation by 80% on average (Ito et al., 2002; Abraham et al., 2005). However, one challenge
with existing transgenic mosquito models is reduced fitness such that the transgenic mosquitoes
cannot survive in the wild (Abraham et al., 2005; Enserink, 2002).
Paratransgenesis is an appealing alternative to transgenesis because the varying mosquito
midgut microflora typically provide several bacterial species to work with. Researchers have
discovered a different profile of species of bacteria in each mosquito midgut; Straif et al. found
the same majority bacterial genus in only 3% of studied Anopheles mosquitoes while GonzalezCeron found that the majority of mosquitoes had no cultivatable bacterial inhabitants (Straif et
al., 1998; Gonzalez-Ceron et al., 2003).

This means that in order to create a widespread

paratransgenesis model to fight mosquito borne diseases, a bacterial strain may need to be
adapted to live in the mosquito gut prior to any genetic modifications (Riehle et al., 2005). It is
16

also of note that the number of bacteria increase exponentially when the mosquito takes a blood
meal; this may or may not assist with the efficiency of a paratransgenic model (Riehle et al.
2005). Another consideration in the development of a paratransgenic model in mosquitoes is
that only one bacterial genus, Asaia, is passed from generation to generation meaning that any
paratransgenesis model would need to target each generation of adult mosquitoes (Favia, 2008;
Riehle et al., 2005).
While transgenesis and paratransgenesis are both actively researched in the lab; there is
no consensus on how they can be implemented in the natural world (James, 2011).

The

Cartagena treaty, adopted in 2003 by 168 countries, is an agreement on the handling, transport,
and use of living modified organisms; however, transgenic and paratransgenic organisms are not
thoroughly covered in the treaty (Secretariat, 2000). It is safe to say that safety standards as
stringent as those required for vaccine trials will be required if not even more restrictive due to
the potential effects on human inhabitants of test areas who have not agreed to participate in the
study (Enserink, 2002). Most researchers would agree that preliminary cage tests need to be
conducted but choosing locations for any field tests will prove difficult as they should occur in
an area from which it is difficult for the mosquitoes to escape (Enserink, 2002). Any field test
will need to be handled with utmost care and community awareness so as not to create health
hazards and/or bad publicity leading to public opposition of field tests and the inability to use
any new genetic tools that are being created around the world (Subbaraman, 2011).
Researchers have discovered a peptide that is capable of hindering the development of
Plasmodium in the mosquito host by competing with the parasite for binding to the microvilli of
the mosquito midgut. Salivary gland and midgut peptide 1 (SM1) was described by Ghosh et. al.
to potentially competitively bind to the same ligand on the mosquito midgut lumen as the malaria
17

parasite Plasmodium berghei in mice (Ghosh et. al., 2001). This twelve amino acid peptide
strongly inhibits the parasite from entering the salivary glands and crossing the midgut epithelia
(Ghosh et. al., 2001).
1.5 Combining Phage Display and Vector Borne Disease Control
The intention here is to develop a novel system to deliver the SM1 peptide to the
mosquito gut to inhibit the life cycle of the parasite in the mosquito. The use of phages and
phage display technology is proposed in a method we call phagotransgenesis. This thesis
describes preliminary work to develop a phage display system using only one genetic element to
aid in the prevention of the transmission of the malaria parasite and expand that technology to
aid in the prevention of the transmission of other insect borne parasites.
Here it is hypothesized that any filamentous phage and its host can be used for foreign
peptide production and expression with only one genetic element.

Furthermore it is

hypothesized that a foreign gene inserted downstream of the major coat protein in filamentous
phages will be expressed by the same promoter. Because the major coat protein gene is highly
expressed it is assumed that the inserted foreign gene will also be highly expressed.
Due to the ultimate goal of using phages as in phage display to block the development of
the malaria parasite in the anopheline mosquito, a bacteria found to be a natural inhabitant of the
mosquito gut was selected. Through an extensive literature review a list of bacteria found to be
naturally occurring in the gut of anopheline mosquitoes was compiled (Table 2).
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Table 2: Bacteria naturally found in the mosquito midgut
Mosquito

Bacteria

Reference

Anopheles
Albimanus
(Mexico)

Serratia marcescens, Enterobacter
cloacae,Enterobacter amnigenus 2, Enterobacter
sp., and Serratia sp.

GONZALEZ-CERON et
al., J. Med. Entomol.
40(3): 371Ð374 (2003)

Anopheles
darlingi (South
America)

Aeromonas, Pantoea and Pseudomonas*,
Enterobacter hormaechei-cluster

TERENIUS et al.,
Marinotti J. Med.
Entomol. 45(1): 172Ð175
(2008)

Anopheles
gambiae,
Anopheles
funestus (Africa)

Culex
quinquefasciatus

Lindh, Olle Terenius, and
Nocardia corynebacterioides, Acidovorax
Ingrid Faye Appl Environ
temperans, Mycoplasma wenyoniid,
Microbiol. 2005
Stenotrophomonas maltophilia, Stenotrophomonas
maltophilia, Stenotrophomonas sp., Spiroplasma sp., November; 71(11): 7217–
7223.
Paenibacillus sp., Anaplasma ovis, Ehrlichia sp..
Aeromonas hydrophila, Aeromonas sp.
Acinetobacter junii, Ac. calcoaceticus, Aeromonas
culicicola, Bacillus thuringiensis, Microbacterium
oxydans, Pantoea agglomerans, Pseudomonas
aeruginosa*, Staphylococcus epidermidis,
Stenotrophomonas maltophila

*Shown in red are the bacteria species selected for the present work.
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PIDIYAR,Am. J. Trop.
Med. Hyg., 70(6), 2004,
pp. 597–603

From this list, Pseudomonas aeruginosa was selected because it is well characterized and
is a host to well characterized filamentous bacteriophages. It was important that the selected
bacteriophages have a small genome to make genetic manipulations possible. Pseudomonas
aeruginosa strain PAO1 phage Pf3 is a highly characterized and studied filamentous phage
which has a known genome of 5833 nucleotides.
As a proof of principle, Pseudomonas aeruginosa strain PAO1 specific filamentous
phage Pf3 was first used to express EGFP, a reporter gene. The gene coding for EGFP was
placed immediately downstream of gene VIII, the major coat protein gene. After inserting the
EGFP gene into the Pf3 genome, creation of a type 88 phage display system using EGFP in Pf3
was attempted. Any phage coat protein may be used for phage display, however gene VIII, the
major coat protein, is the most popular. The major coat protein was used here due to the high
number of copies of the protein required to create a phage particle. As previously described,
three types of phage display may be accomplished using the major coat protein: Type 8, Type
8+8, and Type 88. Type 88 was chosen because Type 88 typically produces a viable phage
particle with a coat comprised of mostly wild type major coat protein and a few fused coat
proteins. In this construct, a second copy of the major coat protein gene is fused to a foreign
peptide gene and inserted into the wild type phage genome.
Subsequent to genetic manipulations of phage Pf3 to insert the EGFP gene, similar
genetic manipulations were conducted to create a phage Pf3 that expressed the SM1 gene. This
Pf3-SM1 construct is believed to express SM1 fused to a second copy of the Pf3 major coat
protein such that it is on the phage coat as in Type 88 phage display. As an extension of this
approach, EGFP expression systems similar to the initial Pf3-EGFP construct were created in
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Pseudomonas bacteriophage Pf1 and Escherichia coli bacteriophage M13 such that the EGFP
gene was not fused to the major coat protein.
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2. Materials and Methods

2.1 Genetic Engineering of bacteriophage Pf3 to Express the Enhanced Green
Fluorescent Protein (EGFP) Gene
2.1.1 PCR Amplification
Due to the small genome size of phage Pf3, the entire genome can be amplified using
polymerase chain reaction (PCR). We amplified the whole genome of bacteriophage Pf3 using
proofreading polymerase (Exact Polymerase, 5 Prime, Gaithersburg, MD) by PCR using the
following program: 95 C 5min (94 C 30sec, 58 C 30sec, 72 C 14min)x35 14 C forever.
Oligonucleotide primers were designed such that PCR resulted in the linearization of the Pf3
phage circular DNA with the opening point of the circular DNA between gene VIII and the
transcription termination signal of the phage genome (Table 3 and Figure 5).
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Table 3: Oligonucleotides for the genetic engineering of bacteriophage Pf3 with the EGFP gene
Primer Name
Primer Sequence
a
For amplification of the Pf3 genome
AGACCAACTAGTGCCAAAAGCCCAAGGACGGATC
Pf3MCP50upSpeI
Pf3MCP50dwBglII CGACCAGATCTCTCAATCGTTATAAGGGGGCTTCG
b
For amplification of the EFGP gene
ACATCTAGAAAGGAGATATATACATGAGTAAAGGAGAAGAACTTTTC
EGFPFXbaI
CCTGGATCCTTATTTGTATAGTTCATCCATGC
EGFPFRBamHI
c
For sequencing around the insertion site
TGGGCTGAACGTTCAGATTTGC
Pf3-8_seq2
GAGCAACAATCAAACGACCCT
Pf350R_seq
d
For amplification of the Pf3-G10 genome
ACCGGATCCTTTGTATAGTTCATCCATGCCATG
G10upBHI
Pf3MCP50dwSpeI CACACTAGTCTCAATCGTTATAAGGGGGCTTC
e
For assembling and amplifying the Pf3 modMCP gene
ATG CAA TCC GTG ATT ACC GAT GTG ACG GGC CAA CTG ACA GCT GTG
modMCPF
ACC ACC ATT GGT GGT GCC ATT ATT GTT

CAA GCT GAT ATC

modMCPstopc

TCA AAA GAA TTG CGC TTT GAT CCA ACG AAT ACC CAG CAC AAC GGC GGC CAG AAC AAT
AAT GGC ACC ACC AAT GGT GGT GAT ATC

8hingeBgIIF
8XbaIR

CCTAGATCTGGTGGAGGCTCAGGCGGAATGCAATCCGTGATTACCGATG
CACTCTAGATCAAAAGAATTGCGCTTTGATCC

a

Oligonucleotide primers for linearizing the Pf3 phage genome and inserting the EGFP gene
amplified with oligonucleotide primers EGFPFXbaI and EGFPFRBamHIb.
c
Oligonucleotide primers for amplification and sequencing of the regions around the insertion
site.
d
Oligonucleotide primers for linearizing the Pf3-G10 phage genome and inserting the modMCP
gene assembled with oligonucleotide primers modMCPF and modMCPstopc and amplified with
8hingeBgIIF and 8XbaIR e.
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Figure 5:Insertion site of EGFP in the Pf3 genome. EGFP gene was inserted between gene VIII
which codes for the Major Coat Protein of Pf3 and the phage transcription termination signal. The
EGFP gene was immediately preceded by a ribosomal binding site. Genome map created using
CGView.
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Restriction enzyme recognition sequences were added to each oligonucleotide primer
such that the resulting linear DNA had a Spe I site on one end and a Bgl II site on the other end
(Figure 6).
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Figure 6: Steps for constructing the recombinant phage Pf3-G10. The genome of
bacteriophage Pf3 is amplified by PCR and digested with restriction enzymes. The
oligonucleotide primers used to linearize Pf3 are shown by the small black lines leading
away from the opening site indicated by the blue line. The EGFP gene is amplified from
a plasmid and digested with restriction enzymes. The two digested fragments are then
ligated together to form a double stranded recombinant molecule.
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The EGFP gene was amplified by PCR with a proofreading enzyme (Exact Polymerase, 5
Prime, Gaithersburg, MD). Oligonucleotide primers for the reaction were designed such that the
entire gene was replicated (Table 3). Restriction enzyme recognition sites were added to each
primer such that the result of the PCR was double-stranded, linear DNA with a restriction
enzyme recognition site on each end (Figure 4).

Additionally on the forward priming

oligonucleotide, the nucleotide sequence of a known ribosomal binding site (RBS) of several
genes of Pseudomonas was included (Avichezer, 1992; Shine and Dalgarno, 1975).
2.1.2 Purification of PCR Products
The PCR products were purified using the magnetic beads AMPure® XP (Ampure,
Beckman Coulter Genomics, Danvers, MA) according to the manufacturer’s protocol. Briefly,
90 l of the magnetic bead suspension are added per 50 l of PCR mixture, homogenized and left
for 5 minutes at room temperature. A magnetic base is used to separate the magnetic beads
containing the DNA from the liquid. After the samples had been on the magnetic base long
enough for the beads to form a firmly aggregated pellet on the tube wall, approximately 5
minutes, the liquid is carefully removed. Two hundred microliters of 70% ethanol are used to
rinse the pellet twice and the tube was allowed to dry in a 37 C air incubator. Once dry the tube
is removed from the magnetic holder and the magnetic beads were suspended in 20 l of water to
elute the bound DNA. The suspension is allowed to sit at room temperature for 5 minutes then
placed back on the magnetic base until the beads forme a firmly aggregated pellet on the tube
wall (approximately 5 minutes). The liquid containing the DNA was recovered and stored at –
20 C until use.
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2.1.3 Restriction Enzyme Digestion of Purified PCR Products
The Pf3 DNA PCR product was digested overnight in a 37 C water bath with the
restriction enzymes using the suggested double digestion manufacturer’s buffers (New England
Biolabs, Inc., Ipswich, MA). Different restriction enzymes were selected to promote correct
orientation of an inserted gene into the opening point of the Pf3 genome. This strategy was used
throughout the entire project.
The EGFP-containing PCR product was digested overnight in a 37 C water bath with the
restriction enzymes Xba I and Bam HI (New England Biolabs, Inc., Ipswich, MA). Different
restriction enzyme sites compatible with those used in Pf3 were selected for the EGFP gene so
not to recreate these restriction enzyme sites after ligation. This was done so that the same
restriction enzyme sites could be re-introduced in future engineering without the concern of
cutting the DNA at sites other than the desired ones.
2.1.4. Ligation of the Digested PCR Products
Digested Pf3 and the PCR amplified EGFP DNA were mixed at the ratio of 1 Pf3 to 5
EGFP DNA molecules and ligated using T4 DNA ligase (New England Biolabs, Inc., Ipswich,
MA) in a volume of 20 l. The reaction was left at room temperature overnight. The ligated
DNA was purified with magnetic beads as previously described above and used for transfection
of P. aeruginosa PAO1 competent cells.
2.2 Transfection of Pseudomonas. aeruginosa PAO1 with the Ligated DNA
2.2.1 Competent Cell Preparation
The method used for transfection was electroporation. Electro-competent P. aeruginosa
PAO1 cells were prepared as described by Choi et al (2005). Briefly, PAO1 cells were
inoculated in 5 ml of LB broth supplemented with 50 ug/ml of kanamycin and grown overnight.
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One and a half milliliters of the overnight culture was centrifuged at room temperature for 4
minutes at 17,000xg to pellet the cells. The supernatant was removed, the cells re-suspended in
100 l of 10% sucrose then re-pelleted. This procedure was repeated three times at room
temperature. The final cell pellet was re-suspended in 40 l of ten percent sucrose. The electrocompetent cells were stored on ice or used immediately.
2.2.2 Transfection
Four microliters of ligated Pf3-EGFP DNA were added to 40 l of freshly prepared
competent cells. The sample was transferred into an electroporation cuvette with a 2 mm gap
(Fisher Scientific, Pittsburg, PA) and electroporated using the following electroporator settings:
200 Ohms resistance, 25 FD capacity, and 2.5 set volts with 2.51 actual volts and a time
constant of 3.9 seconds (Biorad Gene Pulser II, Hercules, CA).

Immediately after

electroporation, one milliliter of super optimal broth with catabolite repression (SOC; Hanahan,
1983) was added to the cell suspension, and two different aliquots were plated, 100 l and 300
l, on LB broth agar plates containing 50 g/ml of kanamycin with 3 ml of 0.75% top agar. To

the 100 l cell aliquot, 200 l of fresh PAO1 cell culture was added prior to plating to insure a
bacterial lawn with proper density. The plates with the transfected PAO1 cells were incubated at
room temperature overnight.
2.3 DNA Sequencing of Engineered Phage Pf3 Expressing EGFP
2.3.1 Screening of Recombinant Phages by Fluorescence Visualization
Transfected PAO1 cells expressing EGFP were visualized in a gel imager (Alpha Imager,
Alpha Innotech, Santa Clara, CA) equipped with a 488 nm wavelength filter on the UV light
source. EGFP fluorescence was recorded using a camera with an emission filter of 500 nm
wavelength. Fluorescing phage plaques were isolated and further characterized.
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2.3.2 Amplification of Recombinant Pf3 at the EGFP Insertion Site and DNA
Sequencing
To confirm insertion of the EGFP gene into the Pf3 genome, a segment of the
recombinant phage genome containing the EGFP gene was amplified by PCR using Hotmaster
Taq DNA polymerase (5 Prime, Gaithersburg, MD). PCR primers used for the amplification are
shown in Table 2; one anneals upstream of the EGFP gene insertion site while the other anneals
downstream of the same site such that an amplified fragment contains the EGFP gene as well as
the segments of the Pf3 genome on either side of the inserted gene. Amplified fragments from
the screened recombinant phages were visualized by agarose gel electrophoresis and compared to
lambda DNA cut with the restriction enzyme Hind III (New England Biolabs, Inc., Ipswich, MA)
to estimate the lengths of the amplified fragments. Fragments showing the expected length were
submitted the VCU Nucleic Acid Research Facilities (NARF) for sequencing using the Sanger
method (Figure 7).
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Figure 7: Amplification of recombinant phage Pf3-G10 and wild type Pf3 genomes. The
phage constructs are marked and compared to lambda DNA cut with the Hind III restriction
enzyme. Markers on the right indicate the nucleotide size of each band in the size marker.
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2.4 Construction of Type 88 Phage Display in Phage Pf3 with EGFP
2.4.1 Recombinant Phage DNA Manipulation
The genome of the Pf3 phage engineered to express EGFP (Pf3-G10) was amplified by
PCR with primers shown in Table 2 so that it was linearized with the EGFP gene on one end and
the phage transcription termination signal on the other end (Velocity DNA Polymerase, Bioline,
Taunton, MA). The modified major coat protein gene (modMCP) was produced by annealing
oligonucleotides and then amplified from the annealed oligonucleotides using primers with
restriction enzyme recognition sites (Table 2). This was not an exact replica of the MCP gene
already present in the Pf3 genome; approximately every 6th codon was modified for a total of
seven modified nucleotides. Due to synonymous codon usage, the amino acid sequence was not
modified (Figure 8). Based on Pierce, this created a more stable phage genome than having two
identical copies of the MCP because it decreased the likelihood of genetic deletions in the phage
resulting from homologous recombination (Pierce, 1989).
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Pf3 MCP gene
ATGCAATCCGTGATTACTGATGTGACAGGCCAACTGACAGCGGTGCAAGCTGATATCACTACCA
TTGGTGGTGCTATTATTGTTCTGGCCGCTGTTGTGCTGGGTATTCGCTGGATCAAAGCGCAATT
CTTTTGA
Pf3 modMCP gene
ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCTGATATCACCACCA
TTGGTGGTGCCATTATTGTTCTGGCCGCCGTTGTGCTGGGTATTCGTTGGATCAAAGCGCAATT
CTTTTGA
Amino-acid sequence of Pf3 MCP = modMCP
MQSVITDVTGQLTAVQADITTIGGAIIVLAAVVLGIRWIKAQFF*

Figure 8: Changes of bases in the Pf3 MCP gene sequence for the synthesis of the modMCP
gene. The 7 bases changed in modMCP relative to the wild type MCP gene are shown red.
These changes did not affect the amino-acid sequence of modMCP.
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2.4.2 PCR Amplification Digestion with Restriction Enzymes
The amplified Pf3-G10 genome was digested with restriction enzymes Bam HI and Spe I
while the amplified modMCP gene was digested with Bgl II and Xba I (New England Biolabs,
Inc., Ipswich, MA). Magnetic beads were used along with a magnetic base to concentrate and
purify the PCR product digestions as previously described (Ampure, Beckman Coulter
Genomics, Danvers, MA).
2.4.3 Ligation
Digested Pf3-G10 DNA and modMCP DNA were mixed at a ratio of 1 Pf3-G10 to 5
modMCP DNA molecules and ligated using T4 DNA ligase and the manufacturer’s buffers
(New England Biolabs, Inc., Ipswich, MA) in a volume of 20 l. The reaction was left at room
temperature overnight.

The ligated DNA was purified with magnetic beads as previously

described above and used for transfection of PAO1 competent cells. Here a modified copy of the
Pf3 major coat protein was inserted so that it was hinged to the EGFP gene.
Competent cell preparation, transfection, and verification of expression were conducted
as previously described in 2.2 and 2.3. The resulting recombinant phage was named Pf3-G10SH (Figure 9).
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Figure 9: Steps for constructing the recombinant phage Pf3-G10-SH. The genome of
bacteriophage Pf3-G10 was amplified and digested with restriction enzymes. The point of
linearization is indicated by the red line an d the oligonucleotide primers are indicated by the
small green line and the small black line moving away from the point of linearization. The
modified MCP gene was created by annealing two oligonucleotides together and then amplified
by PCR and digested with restriction enzymes. The two digested fragments were then ligated
together to form a double stranded recombinant phage.

35

2.5 Non-denaturing SDS-PAGE
Cultures of uninfected PAO1, wild type Pf3 infected PAO1 cells, Pf3-G10 infected
PAO1 cells, and Pf3-G10-SH infected PAO1 cells were grown for 18 hours in LB supplemented
with 50 g/ml of kanamycin with shaking at room temperature. The cells from 1.5 ml of culture
were harvested by centrifugation and the supernatant was removed to a fresh tube. The cell
fraction was treated with 1.5 ml BugBuster Protein Extraction Reagent (EMD Chemicals,
Gibbstown, NJ) which lysed the cells without denaturing proteins. Each sample from the lysed
cell pellet and from the supernatant was passed through a .22 m syringe filter and then
concentrated using 10K column filters (Millipore, Billerica, MA). Samples were loaded on to a
pre-cast 12% polyacrylamide gel (Mini-Protean TGX, Biorad, Hercules, CA) after being
combined with Native Sample Buffer (Biorad, Hercules, CA). The gel was run for 30 minutes at
220V and samples expressing EGFP were visualized in the gel imager equipped with a 488 nm
wavelength filter on the UV light source. EGFP fluorescence was recorded using a camera with
an emission filter of 500 nm wavelength.
2.6 Construction of Pf3-SM1(4)
2.6.1 SM1(4) DNA Amplification
The SM1(4) cassette consists four tandem copies of the SM1 peptide coding sequence
and was amplified from the plasmid PDB48(SM1)4, kindly provided by Dr. Sibao Wang from
Johns Hopkins School of Public Health. Oligonucleotide primers SM1-4FATGblunt and SM14RBHI were used to amplify the SM1(4) cassette (Table 4).
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Table 4: Oligonucleotides for the genetic engineering of bacteriophage Pf3-G10-SH with
SM1(4) gene cassette
Primer Name
Primer Sequence
a
For amplification of Pf3-G10-SH genome and replacement of EGFP gene
G10EGFPBH1dwn
ACCGGATCCAGTAAAGGAGAAGAACTTTTCAC
G10RBSup
CATGTATATATCTCCTTTCTAGTGCC
b
For amplifying SM1(4) gene cassette
SM1-4FATGblunt
ATGGCTAGCCCCTGTCAGCG
SM1-4RBHI
CCCAGGTCCCGGGGGTGGATCCGT
c
For sequencing around the insertion site
Pf3-8_seq2
TGGGCTGAACGTTCAGATTTGC
Pf350R_seq
GAGCAACAATCAAACGACCCT
a

Oligonucleotide primers for linearizing Pf3-G10-SH phage genome and replacing the EGFP
gene with the SM1(4) gene cassette amplified with oligonucleotide primers SM1-4FATGblunt
and SM1-4RBHIb.
c
Oligonucleotide primers for amplification and sequencing of the regions around the insertion
site.
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.
2.6.2 Ligation, Transfection, and Testing Putative Recombinant Phages
The amplified SM1(4) cassette was ligated into Pf3-G10-SH linearized by PCR with
oligonucleotide primers listed in Table 4. The PF3-SM1(4) ligated DNA was transfected into
competent PAO1 cells as described previously in 2.2 and 2.3 (Figure 10).
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Figure 10: Steps for constructing a the recombinant phage Pf3-SH-SM1(4). The genome of
bacteriophage Pf3-G10-SH is amplified and digested with restriction enzymes. The primers
are indicated by the small black line and small pink line moving away from the EGFP gene.
The SM1(4) cassette was amplified from plasmid PDB48(SM1)4. The two digested
fragments were then ligated together to form a double stranded recombinant phage.
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2.7 Construction of Pf1-G and M13-G
Manipulations of phages Pf1 and M13 were conducted as previously described to
construct phage Pf3-G10. The EGFP oligonucleotides used for Pf1 and M13 were the same as
those used for phage Pf3. Oligonucleotide primers were unique for each phage; those for phage
Pf1 can be found in Table 5 and those for phage M13 can be found in Table 6.
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Table 5: Oligonucleotides for the genetic engineering of bacteriophage Pf1 with the EGFP gene
Primer Name
Primer Sequence
a
For amplification of the Pf1 genome
AGACCAACTAGTCACACCGACCAGAGCACCCG
Pf1MCP5upSpeI
CGACCAGATCTGTTGGGGGCGTTCTTCGCCG
Pf1MCP5dwnBglII
b
For amplification of the EFGP gene
ACATCTAGAAAGGAGATATATACATGAGTAAAGGAGAAGAACTTTTC
EGFPFXbaI
CCTGGATCCTTATTTGTATAGTTCATCCATGC
EGFPFRBamHI
c
For sequencing around the insertion site
CGGTGAACTGTCCATTGAGC
Pf18R_seq
CCTCGTTCCGCAACCTGT
Pf1MCPF_seq
a

Oligonucleotide primers for linearizing the Pf1 phage genome and inserting the EGFP gene
amplified with oligonucleotide primers EGFPFXbaI and EGFPFRBamHIb.
c
Oligonucleotide primers for amplification and sequencing of the regions around the insertion
site.
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Table 6: Oligonucleotides for the genetic engineering of bacteriophage M13 with the EGFP gene
Primer Name
Primer Sequence
a
For amplification of the M13 genome
CAACTAGTCTTTTGGAGCCTTTTTTTTTGGAGATTTTC
M138dwnSpeI
CGACCTGATCAGAGCCTTTAATTGTATCGGTTTATCAG
M138upBclI
b
For amplification of the EFGP gene
ACATCTAGAAAGGAGATATATACATGAGTAAAGGAGAAGAACTTTTC
EGFPFXbaI
CCTGGATCCTTATTTGTATAGTTCATCCATGC
EGFPFRBamHI
c
For sequencing around the insertion site
GCGCAACTATCGGTATCAAGC
M138dwn_seq
TCAACAGTTTCAGCGGAGTGAG
M138up_seq
a

Oligonucleotide primers for linearizing the Pf1 phage genome and inserting the EGFP gene
amplified with oligonucleotide primers EGFPFXbaI and EGFPFRBamHIb.
c
Oligonucleotide primers for amplification and sequencing of the regions around the insertion
site.
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2.8 Identification of Promoter Sequences
An online promoter prediction program (Neural Network Promoter Prediction, Berkeley
Drosophila Genome Project) was used to predict promoters in the genomes of Pf3, Pf1, and M13
in order to predict gene expression in these phages.
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3. Results

3.1 Insertion of EGFP Gene into the Pf3 Genome (Pf3-G10)
PCR

amplification

was

conducted

on

potentially

recombinant

phages

with

oligonucleotides that amplified a segment of the phage genome containing the EGFP gene. The
PCR product was analyzed by agarose gel electrophoresis and the results are shown in Figure 7.
Recombinant phages that produced PCR products about 1300 bases long, the expected length of
the EGFP gene combined with flanking Pf3 gene segments, were sequenced (Figure 11).
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Figure 11: The DNA sequence of the EGFP gene insertion site in Pf3-G10. The 3’ end of the
original Pf3 MCP gene is shown in the second line. The ribosomal binding site (RBS)
sequence and its position in relation to the ATG of the EGFP gene is shown in the third line.
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A copy of the EGFP gene was successfully inserted into the wild type Pf3 genome to
produce a recombinant phage named Pf3-G10. This includes the ribosomal binding site (Shine
and Dalgarno, 1975) as characterized in Pseudomonas (Avichezer, 1992).
3.2 Expression of EGFP Gene by Phage Pf3
EGFP fluorescence was observed on phage plaques on bacterial lawns, and in liquid
bacterial cultures (Figures 12). The plaque morphology of the recombinant phage is similar to
that of the wild type Pf3 and is shown in Figure 12 (A and B). Under the fluorescent microscope
cells infected with pF3-G10 is readily seem
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B

A

C

Figure 12: Pseudomonas aeruginosa bacteria infected with Pf3 engineered with the EGFP
gene (Pf3-G10). A) Colonies of G10 infected cells viewed under white light. B) Colonies
of G10 infected cells viewed under UV light through a filter of 488 nm. C) Liquid culture
of phage infected cells (100X) under the microscope with filter of 488 nm, photo courtesy
of Najla Matos of the facilities of Instituto de Pesquisas em Doenças Tropicais
(IPEPATRO), Porto Velho, RO, Brazil.
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3.3 Creating Type 88 Phage Display in Pf3
3.3.1 Synthesis of Modified Major Coat Protein (modMCP) Gene
To create modified Pf3 major coat protein, two partially overlapping,
complimentary oligonucleotides were synthesized and annealed. The nucleotide sequence of the
major coat protein was modified while the amino acid sequence remained the same. This was
done because work by Pierce shows an increased possibility of genetic deletions of a second
exact copy of a gene inserted into a bacteriophage (Pierce, 1989). This fragment was then
amplified by PCR and analyzed by agarose gel electrophoresis (Figure 13).

48

A
ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCTGATATCACCACCATTGGTGGTGCCATTATTGTT
CTATAGTGGTGGTAACCACCACGGTAATAACAAGACCGGCGGCAACACGACCCATAAGCAACCTAGTTTCGCGTTAAGAAAACT
ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCTGATATCACCACCATTGGTGGTGCCATTATTGTTGACCGGCGGCAACACGACCCATAAGCAACCTAGTTTCGCGTTAAGAAAACT

B
CCTAGATCTGGTGGAGGCTCAGGCGGAATGCAATCCGTGATTACCGATG
ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCT|ACCGGCGGCAACACGACCCATAAGCAACCTAGTTTCGCGTTAAGAAAACT
CCTAGTTTCGCGTTAAGAAAACTAGATCTCAC

Figure 13. Synthesis of the Pf3 modified major coat protein. A) Oligonucleotides
modMCPF and modMCPStopC, shown in red, were annealed to create a nucleotide
sequence with overhanging ends. The consensus sequence of the two anneal
oligonucleotides is shown in green. B) The annealed oligonucleotides, shown in green
with a purple line indicated a break in the sequence, were then amplified by PCR using
oligonucleotides 8XbaIR and 8hingeBgIIF, shown in blue, which contained restriction
enzyme recognition sites.
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3.3.2 Insertion of modMCP into Pf3-G10 Genome (Pf3-G10-SH)
After transfection with the Pf3-G10 genome with the inserted modified MCP, potentially
recombinant phages were amplified by PCR and sequenced. From sequence analysis it can be
seen that the modified MCP gene has been successfully inserted into the previously engineered
phage Pf3-G10. This phage, called Pf3-G10-SH for self-helper, could also be viewed as glowing
plaques on a lawn of PAO1 cells. It can be seen that EGFP is being expressed on the lawn of
PAO1 where there are plaques (Figure 14).
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Figure 14: Pseudomonas aeruginosa bacteria infected with Pf3-G10 engineered with a
modified MCP gene (Pf3-G10-SH) A) Colonies of Pf3-G10-SH infected cells viewed under
white light. B) Colonies of SH infected cells viewed under UV light.
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3.4 Fate of the EGFP in PAO1 Infected with Pf3-G10 and Pf3-G10-SH .
Due to the ultimate goal of developing a phagotransgenesis model to combat the malaria
parasite, it is important to know the location of the expressed foreign peptide. For applications in
disease research it is imperative that the foreign peptide be released from the cell so that it may
come in contact with the extracellular environment. To analyze the location of the expressed
foreign protein, a non-denaturing protein gel of both the supernatant and cell fractions of 18 hour
culture of uninfected PAO1 cells, PAO1 cells infected with wild type Pf3, PAO1 cells infected
with Pf3-G10 and PAO1 cells infected with Pf3-G10-SH was conducted (Figure 15).
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Figure 15. Non-denaturing Protein Gel of Uninfected PAO1 cells, PAO1 Cells Infected with
Wild Type Pf3, PAO1 Cells Infected with Pf3-G10, PAO1 Cells Infected with Pf3-G10-SH,
and Their Respective Supernatants photographed under UV light with a black and white
camera. There are clearly no bands in either of the PAO1 cell column or in the PAO1 cell
supernatant column. The Pf3 infected PAO1 cells show no bands in either the cell or
supernatant columns. Both clones Pf3-G10(*) and Pf3-G10-SH(^) contain a copy of the EGFP
gene and have visible bands shown on the gel in both the cell fraction columns and the
supernatant fraction columns. This indicates that not only is EGFP being produced by the cell,
it is located outside of the cell.
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The cell fraction which would contain any foreign protein that had not been secreted from the
cells was separated by filtration from the supernatant fraction which contained any proteins
secreted from the cells. Fluorescing bands of EGFP protein can be seen to indicate the presence
of the EGFP protein in the supernatant of both the Pf3-G10 and the Pf3-G10-SH as well as in the
cell fraction of both Pf3-G10 and Pf3-G10-SH. The Pf3-G10-SH lane indicates a band of protein
that migrated slower than the band produced by Pf3-G10 which indicates that the EGFP protein
produced by Pf3-G10-SH infected PAO1 is larger than that produced by Pf3-G10 infected PAO1
due to additional amino acids that were fused downstream of the EGFP gene in an attempt to
create a fusion protein.
3.5 Sequence Analysis of Pf3-G10-SH
Upon further analysis, it was discovered that even though the fully modified MCP was
successfully inserted into engineered phage Pf3-G10, the modified MCP is not in the same
reading frame as the EGFP gene and therefore EGFP is not fused to modMCP protein.
3.6 Insertion Replacement of SM1 Gene into Pf3-G10-SH
Even though creation of Type 88 phage display using bacteriophage Pf3 was
unsuccessful with EGFP, the engineered phage Pf3-G10-SH may be used as a vector for
inserting other foreign peptides into the Pf3 genome. The Pf3-G10-SH genome was processed as
described above and the SM1(4) cassette was successfully inserted (Figure 16).
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Figure 16: Insertion site of the SM1(4) gene cassette. Above the red line, the Pf3-SH-SM1(4)
construct sequence can be seen to contain the end of the Pf3 MCP gene and the beginning of the
SM1(4) gene cassette as well as the RBS shown in the blue box. Below the red line, the Pf3-SHSM1(4) construct sequence can be seen to contain the end of the SM1(4) gene cassette as well as
the beginning of the modMCP gene. The SM1(4) gene cassette is in the same reading frame as
the modMCP gene.
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3.7 EGFP Gene Expression in Phages Pf1 and M13
Based upon similar gene organization, the same methods were used to construct
analogous recombinant phages in filamentous phage Pf1 of P. aeuriginosa strain PAK and
filamentous phage M13 of E. coli (Figure 17).
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Figure 17. M13 and Pf1 phages engineered with the EGFP gene. A) Plaques of M13-G phage
visualized by excitation UV light through a 488nm wavelength filter and emission light
captured through a camera equipped with a 500nm wavelength filter. B) Plaques of Pf1-G
infected cells visualized by excitation UV light through a 488nm wavelength filter and
emission light captured through a camera equipped with a 500nm wavelength filter.
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3.8 Promoter Analysis in Phages Pf3, Pf1, and M13
With the goal of identifying putative promoters, the Berkeley Drosophila Genome
Project’s Neural Network Promoter Prediction tool was used to predict potential promoters
within the genomes of phages Pf3, Pf1, and, M13. Because phages use host cell machinery for
transcription of their genome, prokaryotic promoter regions were searched for. A score is
provided for predicted promoters, and the score indicates the percentage of all promoters
recognized at that threshold, as well as the number of false positives. All promoters analyzed
produced a minimum score of .85 indicating that 60% of all promoters were indicated with a
false positive of 0.4% and a correlation coefficient of 0.72. In the three analyzed phages, it can
be seen that known or putative single stranded DNA binding protein is transcribed in frame with
and immediately precedes the major coat protein. This is logical since both the single stranded
binding protein and the major coat protein are highly expressed. Analysis of these three phages
for potential promoters reveals at least one promoter occurring immediately prior to the start of
the single stranded binding protein gene in each phage with two promoters prior to the start of
the single stranded binding protein gene in phages Pf1 and M13. Multiple putative promoters
can be seen in all presented genome maps (Figure 18).
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Figure 18: Alignment of bacteriophage genomes with their respective genes and putative
promoters. For clarity, only the single stranded binding protein (SSBP) is indicated as well as the
major coat protein (MCP) genes, and the two putative promoters located immediately upstream
of the SSBP gene are highlighted in a blue box. The EGFP gene insertion site in each of the
three phage genomes is marked by a purple line. Genome maps created using CGView.
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4. Discussion

4.1 EGFP Gene Expression in phages Pf3, Pf1, and M13
Here it is shown that the EGFP gene can be inserted downstream of the major coat
protein of phage Pf3, Pf1, or M13 and be expressed under the control of the major coat protein
promoter. Since most filamentous phages have a comparable gene organization to the three
systems that have been constructed, this suggests that any filamentous phage can be used to
construct a similar system.

Hence, there may be unlimited potential for this technology.

Furthermore, this expression system could be used in any environment that filamentous phages
are found because the foreign peptide is solely dependent upon expression from the phage’s
promoters.
Additional characterization of the construct would need to be conducted along with
protein size based experiments in order to determine the range of foreign peptides that may be
expressed in this manner. There is no reason to believe that two fused proteins could not be
expressed in this fashion leading to the hypothesis that a foreign gene being fused to a phage
gene could be expressed to create a Type 88 phage display system.
4.2 Type 88 Phage Display in Pf3 with the EGFP gene
For the ultimate goal of using phages as in phage display to block the transmission of the
malaria parasite it is imperative that the foreign peptide be secreted from the host cell. This is of
such great importance because the foreign peptide must be able to compete with the malaria
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parasite for interaction with receptors on the midgut epithelia of the mosquito. Creating a Type
88 phage display system in which the foreign peptide is expressed on the phage coat would be an
ideal system for the foreign peptide to be secreted from the host cell. Type 88 phage display also
meets the need of using only one genetic element. Construction of Type 88 phage display using
phage Pf3 was first attempted using the EGFP gene.
Attempts to construct a phage display system with the EGFP gene on the phage coat of
Pf3 were unsuccessful because the inserted copy of the EGFP gene was not in frame with the
inserted modified major coat protein. The inability to create an appropriate construct may be due
to problems caused by proofreading polymerase used during PCR. The enzyme that was used
disrupts the ends of the DNA strands and may not produce the intended product; this was
discovered well after the experiments had already been conducted and could have easily caused a
few bases to be deleted resulting in the EGFP gene and the modMCP gene being in different
reading frames. Additional characterization of this engineered phage needs to be conducted and
attempts to put the EGFP gene in frame with the modified MCP gene are underway but have
been unsuccessful up to this point.
The success here is in the creation of a replacement vector that can be used for insertion
of other foreign peptides into the genome of Pf3 such that they are fused to the modified major
coat protein and thereby displayed on the phage coat as in phage display. One differentiating
point between this Type 88 system and traditional phage display is the use of a promoter region.
In traditional M13 phage display, a promoter region is inserted into the phage genome so that the
foreign gene is expressed (Sidhu, 2001). Here, the created system does not require a promoter to
be inserted prior to the foreign gene in order for there to be expression. This is likely due to the
location in the bacteriophage genome where the foreign gene fused to the modified major coat
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protein is inserted. The major coat protein is a highly expressed, phage-coded protein and here
the inserted gene fusion is placed immediately after the major coat protein and before the
transcription termination signal.
4.3 Type 88 Phage Display in Pf3 with the SM1 gene
The constructed Pf3 replacement vector was used to insert a gene cassette containing four
copies of the SM1 gene into the Pf3 genome so that they were in frame with the modified major
coat protein. Four tandem copies of SM1 (SM1(4)) were used because it Ito has already shown
that the blocking effect of the protein increased with the number of copies of the protein gene
that were being expressed but that the increase in blocking is insignificant after the fourth copy
(Ito, 2002).
This construct was successfully obtained but optimization is required. As seen in Figure
15, all of the needed pieces are present in the construct; however, there are only two bases
between the ribosomal binding site and the beginning of the SM1(4) cassette. This was not
intentional and, again, is most likely a consequence of the proofreading polymerase which was
used in the PCR amplifications. There is no reason to believe that the SM1(4) cassette is not
being expressed and no reason to believe that it is not fused to the modified major coat protein;
however, optimization of the construct to introduce additional bases between the ribosomal
binding site and the beginning of the SM1(4) cassette would be ideal. Typically in Pseudomonas
the ribosomal binding site is found 6 to 10 nucleotides prior to the beginning of a gene
(Avichezer, 1992, Blumer, 1999; Olins, 1988). Using the same spacing would be ideal when
constructing a recombinant phage to be used in Pseudomonas. Expression would likely be
increased with appropriate placement of the ribosomal binding site as Olins reported a 340-fold
increase in gene expression when using a ribosomal binding site (Olins, 1988).
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4.4 Expressed Foreign Peptide Secretion
As seen in Figure 14, the expressed EGFP, as well as the EGFP fused with additional
amino acids, is being secreted from the cell.

The method of secretion is unknown and

characterization is needed. There are several ways that filamentous phages may be secreted from
host cells, and the expressed EGFP is likely to use one of these methods.
The EGFP may be simply using the host encoded secretion channel as seen in the phage
CTXФ which uses the same host encoded channel as cholera toxin for secretion (Rakonjac,
2011). Alternatively, the EGFP may also be using a phage encoded secretion channel. In either
case the EGFP is being secreted from the host cell as desired; it is imperative that expressed
foreign peptides be secreted from the cell so that they may interact with the extracellular
environment. In presented case of malaria, the SM1 peptide must be secreted from the cell so
that it can competitively bind to the same ligand as the malaria parasite. Secretion may be a
distinct property of EGFP and may not be observed when other foreign proteins are inserted into
the Pf3 genome. Further characterization of the secretion system that is acting in the Pf3-G10
and Pf3-G10-SH constructs needs to be conducted so that this system may be applied to other
foreign proteins. The method of secretion may dictate how this type of system can be used in
the future.
4.5 Promoter Sequence Analysis
There is at least one putative promoter occurring immediately prior to the start of the
single stranded DNA binding protein gene in each of the three phages that were analyzed. This
promoter would act to promote transcription of both the single stranded binding protein as well
as the major coat protein and, in the Pf3, Pf1, and M13 constructs presented here, the foreign
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EGFP gene that was inserted into the phage genome. There were also promoters predicted in the
opposite direction of gene transcription which may play a role in expression control.
Polycistronic gene transcription is highly likely because filamentous bacteriophage genes
are spaced in tandem, without room for individual promoters and there were not promoters
predicted prior to each gene in the phage genomes.
In prokaryotes, there is a promoter region 10 bases upstream from the transcription start
site and a similar structure has been described in bacteriophages (Gershenzon, 2005; Olins,
1988). This is consistent with the predicted promoter sequences in the genomes of phages Pf3,
Pf1, and M13. Here, there were promoters predicted inside of genes which further supports the
idea that the phage genes are organized into operons to control expression levels. Highly
expressed genes such as the single stranded DNA binding protein and the major coat protein
appear to be organized into an operon while the minor coat proteins appear to be organized into
another. When inserting a foreign gene consideration should be given to the operon the gene is
inserted into. Here, high expression of the foreign gene was desired so placing it within a highly
expressed operon was helpful.
4.6 Future Uses
Based on the results, the future implications of foreign gene expression using the systems
similar to those created here are tremendous.

Clearly there is a potential application in

controlling the transmission of the malaria parasite.

While the SM1 protein blocks the

development of the malaria parasite found to infect mice, once a similar protein is found that
block the parasite that infects humans, a phage system that expresses that protein may be easily
constructed following the same protocol used here.
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Other vector borne diseases may also be blocked using this type of system. For instance,
the BMAP-18 peptide, a truncated version of the bovine myeloid antimicrobial peptide – 27
(BMAP-27) is has been reported to block the trypanosomatid parasites that cause Chagas disease
(Haines, 2009). Any filamentous phage-host pair found to naturally occur in the host for the
trypanosomatid parasite may be engineered to express BMAP-18, using the same technique used
here, thereby blocking the parasite. Release of a genetically altered phage is more favorable than
release of a genetically modified insect or bacteria because phages are unable to propagate
outside of their host bacteria meaning that phagotransgenesis is more favorable than transgenesis
or paratransgenesis in blocking vector borne parasites.
4.7 Conclusions
Here a foreign gene has been successfully expressed in bacteriophages Pf3, Pf1, and M13
using the phage’s naturally occurring promoters. This was then applied to create a Type 88
phage display system to control the spread of the malaria parasite. The Type 88 phage display
system met the biggest requirement of a malaria parasite blocking system; one genetic element.
While this phage display system has been designed for use in the control of the malaria parasite,
alternative applications abound.
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